Philipp Starkl
Overview
Explore the profile of Philipp Starkl including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
2073
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Aguilera-Lizarraga J, Reed D, Starkl P, Alpizar Y
Front Immunol
. 2024 Aug;
15:1474270.
PMID: 39192981
No abstract available.
2.
Starkl P, Jonsson G, Artner T, Lenfers Turnes B, Gail L, Oliveira T, et al.
Sci Immunol
. 2024 Aug;
9(98):eadh0545.
PMID: 39178277
Postoperative pain affects most patients after major surgery and can transition to chronic pain. The considerable side effects and limited efficacy of current treatments underline the need for new therapeutic...
3.
Radhouani M, Starkl P
Front Allergy
. 2024 Aug;
5:1423938.
PMID: 39157265
Asthma is a chronic respiratory disease of global importance. Mouse models of allergic asthma have been instrumental in advancing research and novel therapeutic strategies for patients. The application of relevant...
4.
Starkl P, Jonsson G, Artner T, Lenfers Turnes B, Serhan N, Oliveira T, et al.
bioRxiv
. 2023 Jun;
PMID: 37293068
Postoperative pain affects most patients after major surgery and can transition to chronic pain. Here, we discovered that postoperative pain hypersensitivity correlated with markedly increased local levels of the metabolite...
5.
Bulck C, Nystrom E, Koudelka T, Mannbar-Frahm M, Andresen G, Radhouani M, et al.
Sci Adv
. 2023 Mar;
9(13):eadf4055.
PMID: 37000885
The metalloproteases meprin α and meprin β are highly expressed in the healthy gut but significantly decreased in inflammatory bowel disease, implicating a protective role in mucosal homeostasis. In the...
6.
Trained immunity of alveolar macrophages requires metabolic rewiring and type 1 interferon signaling
Zahalka S, Starkl P, Watzenboeck M, Farhat A, Radhouani M, Deckert F, et al.
Mucosal Immunol
. 2022 Jul;
15(5):896-907.
PMID: 35856089
Environmental microbial triggers shape the development and functionality of the immune system. Alveolar macrophages (AMs), tissue-resident macrophages of the lungs, are in constant and direct contact with inhaled particles and...
7.
Shoemaker R, Panettieri Jr R, Libutti S, Hochster H, Watts N, Wingfield P, et al.
PLoS One
. 2022 Jul;
17(7):e0271066.
PMID: 35816490
As ACE2 is the critical SARS-CoV-2 receptor, we hypothesized that aerosol administration of clinical grade soluble human recombinant ACE2 (APN01) will neutralize SARS-CoV-2 in the airways, limit spread of infection...
8.
Gawish R, Starkl P, Pimenov L, Hladik A, Lakovits K, Oberndorfer F, et al.
Elife
. 2022 Jan;
11.
PMID: 35023830
Despite tremendous progress in the understanding of COVID-19, mechanistic insight into immunological, disease-driving factors remains limited. We generated maVie16, a mouse-adapted SARS-CoV-2, by serial passaging of a human isolate. In...
9.
Shoemaker R, Panettieri Jr R, Libutti S, Hochster H, Watts N, Wingfield P, et al.
bioRxiv
. 2021 Sep;
PMID: 34545364
To develop a universal strategy to block SARS-CoV-2 cellular entry and infection represents a central aim for effective COVID-19 therapy. The growing impact of emerging variants of concern increases the...
10.
Stackowicz J, Gaudenzio N, Serhan N, Conde E, Godon O, Marichal T, et al.
J Exp Med
. 2021 Sep;
218(10).
PMID: 34477811
Gain-of-function mutations in NLRP3 are responsible for a spectrum of autoinflammatory diseases collectively referred to as "cryopyrin-associated periodic syndromes" (CAPS). Treatment of CAPS patients with IL-1-targeted therapies is effective, confirming...